although
frequenc
physician
consult
sale
overtheabstract
counter
remedi
establish
high
preval
acut
cough
elderli
epidemiolog
studi
tend
imprecis
howev
respiratori
tract
infect
nose
larynx
andor
bronchi
either
viral
bacteri
far
commonest
caus
acut
cough
especi
frequent
hazard
elderli
commun
live
institutionalis
may
aggrav
problem
varieti
virus
bacteria
incrimin
rhinoviru
influenza
respiratori
syncyti
virus
streptococcu
pneumonia
haemophilu
influenza
bordetella
pertussi
especi
import
viral
infect
readili
lead
communityacquir
pneumonia
success
diagnosi
point
success
treatment
respect
clinic
examin
patient
histori
paramount
supplement
chest
xray
viral
bacteri
cultur
serolog
test
depend
result
test
specif
antibacteri
therapi
may
call
although
disput
merit
antibacteri
therapi
case
uncertain
diagnosi
prevent
prophylaxi
influenza
pneumonia
infect
commend
routin
elderli
especi
commun
treatment
well
use
antibacteri
may
also
direct
inflammatori
infect
process
airway
nonspecif
antituss
therapi
common
usual
highli
desir
prevent
advers
effect
repeat
cough
advanc
antituss
therapi
recent
year
opioid
dextromethorphan
commonli
use
agent
act
central
brainstem
also
larg
placebo
effect
howev
work
much
appreci
patient
partner
moreov
strike
advanc
understand
peripher
sensori
central
nervou
pathway
cough
reflex
recent
year
soon
lead
new
specif
choic
agent
inhibit
cough
patient
probabl
go
either
pharmacist
physician
common
caus
spite
high
incid
cough
chronic
cough
cigarett
smoke
atmospherpopul
littl
inform
exact
ic
pollut
regard
diseas
preval
epidemiolog
relat
age
condit
chronic
obstruct
pulmonari
paediatr
condit
countri
diseas
copd
chronic
bronchiti
cancer
defigur
avail
common
sympvelop
extens
research
patholog
tom
medic
advic
sought
exclud
result
cigarett
smoke
pollut
condit
relat
poverti
war
starvat
larg
limit
studi
involv
seriou
chronic
howev
probabl
major
patient
pulmonari
diseas
ignor
earlier
year
cough
certainli
acut
cough
go
pharmarepetit
cough
cist
rather
physician
therefor
escap
size
problem
reflect
expenepidemiolog
survey
partli
ditur
otc
remedi
coughsandcold
acut
cough
definit
selflimit
cours
two
patient
know
get
better
without
medic
advic
even
chronic
cough
major
cold
induc
cough
billion
spent
us
million
uk
cough
chronic
condit
otc
coughcold
medicin
imposs
may
either
acut
chronic
includ
cough
beto
analys
figur
term
populacaus
postnas
drip
pnd
may
tion
subgroup
individu
medic
relat
acut
chronic
rhinosinus
ursuch
data
avail
ti
cough
continu
mani
week
even
month
symptomat
resolut
us
million
medic
primari
inflammatori
condit
acut
consult
cough
third
attribut
cough
owe
urti
without
acut
acut
tracheobronch
uk
bronchiti
acut
bronchiti
may
occur
without
present
complaint
half
medic
urti
indic
earlier
section
consult
cough
uk
condit
may
lead
chronic
cough
averag
two
consult
everi
year
per
patient
acut
respiratori
tract
infect
wet
dri
cough
adult
attend
gener
practic
later
data
gener
support
high
incid
term
wet
dri
cough
frequent
survey
analys
data
young
adult
use
limit
diagnost
valu
dri
elderli
subgroup
influenza
pneucough
may
point
acut
laryng
urti
monia
death
per
year
us
also
occur
chronic
cough
gastroand
year
age
older
oesophag
reflux
aceinhibit
asthma
discuss
acut
cough
elderli
wet
cough
usual
appli
acut
especi
three
gener
consider
chronic
bronchiti
condit
cf
bronchiectasi
first
sight
wet
cough
acut
chronic
cough
definit
bronchopulmonari
diseas
excess
product
mucu
reach
larsinc
review
deal
acut
cough
must
ynx
caus
cough
expector
howev
defin
uniform
agreement
wet
cough
also
occur
pnd
secret
author
refer
rather
imprecis
acut
aris
upper
airway
selflimit
episod
contrast
chronic
perit
import
note
term
mostli
sistent
cough
three
week
often
taken
qualit
depend
sole
subject
imlimit
acut
phase
week
usual
pression
patient
copiou
amount
mucu
accept
time
acut
cough
becom
collect
sputum
pot
chronic
week
sometim
refer
inaccur
method
add
littl
term
diaga
subacut
recent
studi
show
nostic
valu
borderlin
condit
howev
acut
upper
respiratori
tract
infect
urti
inimport
assess
wet
dryness
fect
agent
defin
cough
could
last
classif
may
elimin
diagnos
week
distinct
may
imporand
point
other
therefor
suggest
certain
tant
provid
limit
defin
therapeut
antituss
approach
condit
clearli
chronic
discuss
review
includ
cough
due
copdchron
bronchiti
bronchopulmonari
cancer
cystic
fibrosi
cf
bronchiectasi
extens
studi
acut
cough
aceinhibit
gastrooesophag
reflux
asthma
children
exampl
relat
infect
habitcough
copd
asthma
cf
may
bordetella
pertussi
cough
may
subacut
includ
acut
episod
cough
eg
acut
bronchitor
chronic
depend
definit
infant
ic
exacerb
copd
underli
caus
bronchiol
infect
respiratori
syncyti
viru
rsv
gener
studi
attend
respiratori
gener
medic
clinic
unit
adult
separ
young
middl
difficult
ascertain
exact
preval
age
elderli
yet
know
spectrum
acut
cough
gener
popul
coughinduc
patholog
chang
age
mani
patient
seek
profession
medic
adult
quantit
physiolog
mechanadvic
consult
pharmacist
instead
therefor
ism
upper
airway
includ
cough
thu
select
bias
may
overestim
incielderli
patient
seem
weaker
cough
resdenc
seriou
caus
cough
acut
pons
distil
water
aerosol
younger
papnd
bronchiti
patient
conditi
must
also
rememb
women
tion
like
go
unit
publish
higher
sensit
coughinduc
aerosol
paper
aetiolog
men
although
shown
acut
rhiniti
rhinosinus
differ
chang
age
genderrel
effect
may
relev
elderli
cough
induc
inflamm
preponder
femal
patient
attend
specialirrit
larynx
trachea
bronchi
ist
cough
clinic
commun
practherefor
infect
nose
pharynx
cantic
per
se
caus
cough
aris
infect
extend
larynx
lower
epidemiolog
tori
tract
nasopharyng
secret
flow
acut
cough
nearli
alway
due
respiratori
larynx
either
stimul
mechan
chemtract
infect
rti
viral
infect
ical
pnd
consid
import
aetiolog
common
caus
typic
cough
nonfactor
chronic
cough
presum
product
dri
without
cough
vicaus
cough
acut
rhiniti
rhinosinus
ruse
account
acut
respiratori
virus
commonli
infect
nose
ill
bacteri
infect
whether
superupp
respiratori
tract
rhinoviru
adenoviru
impos
viral
infect
includ
coronaviru
may
also
spread
lower
aircondit
communityacquir
pneumonia
way
even
rhinoviru
may
prefer
cap
less
common
tabl
list
main
viral
ential
infect
nose
sinc
grow
readili
bacteri
caus
acut
rti
cultur
found
bronchial
biopselect
popul
use
studi
sie
infect
patient
sinc
epidemiolog
acut
cough
case
serotyp
rhinoviru
surpris
elderli
often
institutionalis
home
common
caus
acut
care
facil
children
young
adult
rhiniti
also
major
contributor
lower
respiratori
tract
infect
lrti
commun
especi
elderli
patient
prospect
studi
patient
age
year
rti
lrti
defin
presenc
cough
wheez
andor
chest
pain
urti
absenc
patient
lrt
symptom
urt
symptom
thu
patient
rhiniti
also
lrti
includ
symptom
cough
pathogen
identifi
patient
commonest
pathogen
rhinoviru
coronaviru
influenza
mean
age
year
show
import
influenza
coronaviru
rsv
rti
show
virus
usual
caus
acut
rhiniti
rhithat
older
group
significantli
lrt
noviru
adenoviru
coronaviru
presum
symptom
includ
cough
younger
mean
alway
reach
lrt
mani
instanc
age
year
group
studi
support
caus
bronchiti
moreov
rhinoviru
deimport
virus
associ
common
tect
bronchial
biopsi
patient
urcold
rhinoviru
coronaviru
lrti
ti
high
frequenc
respiracough
elderli
tori
infect
due
rhinoviru
compar
virus
probabl
contribut
frequent
regard
bacteri
infect
due
lrti
especi
elderli
furthermor
streptococcu
pneumonia
haemophilu
inrhinoviru
infect
common
caus
fluenza
although
moraxella
catarrhali
may
also
acut
exacerb
asthma
major
caus
found
acut
exacerb
copd
cf
infect
respiratori
virus
influenza
b
parainfluenza
rsv
probabl
alway
involv
lrt
quit
often
nose
cough
origin
irrit
inflam
incid
lrt
viral
infect
rsv
inflularynx
theoret
seem
unlik
deenza
coronaviru
one
studi
rhinoviru
coronaviru
influenza
anoth
coronsc
mucu
pharynx
would
provid
aviru
rhinoviru
third
group
elderli
adequ
mechan
stimulu
cough
sinc
patient
rsv
isol
frequent
mucu
would
preferenti
swallow
rhinoviru
two
top
list
type
mucu
ascend
trachea
may
contact
viru
isol
group
elderli
patient
vocal
fold
provid
stimulu
cough
howhospitalis
acut
respiratori
diseas
ever
conjectur
due
lack
research
infect
influenza
viru
insight
mucu
flow
stimulu
cough
select
criteria
group
may
differ
certain
urti
frequent
usuprovid
best
represent
gener
popual
lead
cough
expiratori
effort
lation
virus
list
earlier
section
cough
dri
ie
mucu
present
urg
like
respons
case
acut
broncough
may
relat
irrit
larynch
elderli
well
adult
gener
geal
sensori
receptor
note
section
author
would
diagnos
lrti
presenc
cough
may
adult
patient
acut
tracheb
depend
whether
larynx
defin
obronch
develop
pneumonia
bacteri
inpart
urt
lrt
distinct
fection
deep
lung
common
also
import
term
mechan
acut
larynag
elderli
patient
mycoplasma
pneugiti
occur
absenc
tracheobronchi
monia
chlamydia
pneumonia
b
pertussymptom
wheez
chest
pain
mucu
producsi
although
h
influenza
catarrhali
tion
absenc
laryngoscopi
acut
laryngistaphylococcu
aureu
also
detect
ti
identifi
sensat
irrit
one
studi
show
elderli
patient
acut
sore
even
pain
laryng
region
bronchiti
pneumonia
h
influenza
frequent
bacteri
pathogen
setion
associ
acut
cough
diagnosi
rolog
studi
consist
findtherapi
depend
among
factor
ing
b
pertussi
increasingli
identifi
identif
pathogen
patient
acut
bronchiti
probabl
due
diagnosi
manag
common
use
polymeras
chain
reacpati
acut
cough
tion
infect
becom
preval
increas
age
possibl
immun
great
major
patient
diagnosi
may
wane
previous
vaccin
individu
caus
cough
patient
histori
physic
thu
infect
cough
may
common
examin
small
minor
patient
elderli
patient
sinc
bacteri
infect
sophist
test
necessari
may
may
prolong
cours
viral
tracheobronch
especi
true
elderli
symptom
may
cough
may
last
longer
detriment
may
mask
age
patient
cap
usual
present
sympprocess
sign
symptom
may
restrict
tom
includ
cough
acut
bronchiti
four
one
two
part
respiratori
tract
nose
million
patient
us
develop
cap
year
larynx
lung
even
though
infect
probwith
year
old
abli
affect
part
respiratori
system
death
per
year
us
cap
nosi
caus
acut
cough
import
elderli
group
patient
treatment
also
limit
frequent
agent
detect
pneumonia
folspread
infect
low
h
influenza
staphylococcu
aureu
c
wherea
case
acut
cough
start
pneumonia
pneumonia
legionella
pneuvir
infect
develop
bacteri
infecmonia
respiratori
virus
incid
tion
potenti
hazard
state
may
cap
increas
elderli
patient
bacterrequir
specif
therapi
hospitalis
ventiial
spectrum
may
chang
younger
latori
support
may
urgent
requir
adult
without
chemotherapi
note
repeat
vigour
possibl
exist
comorbid
imporcough
may
advers
effect
tant
especi
elderli
consider
elderli
patient
effect
includ
incontin
appli
mani
neurolog
disord
especi
femal
rib
fractur
vagal
parkinson
diseas
cerebrovascular
diseas
mediat
cardiac
instabl
stroke
may
diseas
depress
cough
mechan
aspir
may
viral
infect
also
lead
pneumonia
superimpos
defect
cough
reflex
condit
alcohol
diagnosi
viral
influenza
import
mental
deterior
cough
may
weak
distinguish
common
cold
anticith
chanc
contract
bacteri
pneumonia
pate
possibl
develop
bacteri
pneumoenhanc
nia
lead
appropri
antiinfect
treatment
summari
epidemiolog
studi
acut
cough
underli
caus
identifi
influenza
sudden
onset
malais
mani
viral
bacteri
pathogen
deand
fever
follow
cough
headach
myalgia
tail
pattern
effect
caus
vari
presum
nasal
chest
symptom
cough
combecaus
differ
popul
group
method
monest
symptom
present
patient
studi
gener
pattern
clear
identifi
elderli
sign
symptom
influenza
rang
pathogen
lead
respiratori
condimay
atyp
consist
lowgrad
fever
lassitud
confus
nasal
obstruct
tachymor
accur
delin
sinu
involvepnoea
may
promin
especi
pneumonia
ment
bacteriolog
serolog
test
may
develop
risk
factor
develop
identifi
infect
agent
suggest
appropri
complic
includ
age
year
resid
chemotherapi
nurs
home
chronic
care
facil
variou
acut
bronchiti
chronic
diseas
includ
pulmonari
diseas
frequent
elderli
distinct
viral
bacteri
infeciniti
influenza
may
difficult
distinguish
tion
bronchiti
may
difficult
clinic
examfrom
common
cold
domin
constiin
alon
yet
identif
bacteri
tution
symptom
cours
develop
pneumonia
present
crucial
term
treatrapidli
make
distinct
clear
center
ment
see
section
review
conclud
diseas
control
prevent
us
dechest
xray
cxr
help
clinic
fine
clinic
criteria
influenza
infect
havexamin
chest
patient
histori
ing
fever
least
oral
least
one
howev
may
appli
elderli
may
follow
cough
sore
throat
rhinorrhoea
chest
infect
present
mainli
nonfirst
criterion
fever
may
applic
respiratori
symptom
confus
frequent
elderli
influenza
diagnos
viral
culfal
cxr
strongli
recommend
pneumotur
respiratori
secret
obtain
pharynnia
suspect
although
minor
geal
swab
sputum
nasopharyng
aspir
patient
cxr
sign
margin
may
although
older
method
cultur
may
clearli
distinguish
viral
bacteri
pneuslow
relat
timecours
diseas
monia
nasal
investig
use
rapid
diagnost
test
avail
sputum
gram
stain
cultur
precis
distinguish
influenza
type
valu
disput
moreov
satisfacb
tori
sampl
sometim
difficult
obtain
rsv
infect
seriou
elderli
elderli
one
studi
patient
studi
found
could
aetiolog
agent
identifi
serologpreval
influenza
infect
diagnost
ical
test
particularli
influenza
b
pertussi
test
antigen
detect
cultur
tend
may
inform
help
choosb
slow
rather
insensit
clinic
examin
appropri
therapi
ation
elderli
may
suggest
rsv
rather
influenza
infect
fever
low
grade
may
bacteri
infect
account
major
combin
wheez
clinic
deterioracas
pneumonia
classic
sign
tion
pneumonia
may
insignific
absent
elderli
may
fever
symptom
may
insignific
due
mental
confuher
diagnosi
clear
patient
hission
physic
find
lobar
consolid
tori
symptom
clinic
examin
may
also
absent
hand
tachymain
question
whether
superimpos
bacteri
pnoea
may
conspicu
viral
pneumoinfect
requir
specif
treatment
simpl
radinia
typic
symptom
influenza
deterior
ograph
may
unhelp
sinc
abnorm
develop
sever
cough
sinus
may
detect
computeris
fever
appear
dyspnoea
cyanosi
axial
tomographi
scan
practic
allow
cxr
may
show
bilater
sign
without
consolid
develop
bacteri
pneui
reduc
featur
especi
import
monia
may
signal
recurr
exacercommun
elderli
bation
symptom
prolong
beyond
chemoprophylaxi
antivir
agent
day
appear
area
consolid
effect
prevent
influenza
infect
cxr
base
larg
studi
patient
effect
influenza
perhap
cap
classifi
five
grade
predict
lesser
extent
influenza
b
sialidas
inlikelihood
surviv
patient
lowest
hibitor
may
effect
prevent
score
mortal
rate
less
wherea
influenza
includ
elderli
highest
score
rate
case
pneumonia
especi
cap
vaccithi
approach
could
adjunct
assess
nation
pneumonia
recommend
need
ventilatori
support
patient
age
year
although
often
given
lifetim
probabl
specif
treatment
provid
immun
known
varieti
coughcaus
condit
organ
may
case
revaccin
impli
particularli
valuabecaus
approv
name
drug
also
ble
commun
elderli
avail
vari
wide
countri
antivir
agent
otc
remedi
even
drug
refer
gener
section
indic
section
antivir
agent
select
section
effect
influenza
b
virus
given
within
hour
onset
ill
reduc
sever
durat
diseas
renal
impair
elderli
drug
annual
immunis
influenza
dosag
may
limit
sinc
agent
standard
practic
patient
age
metabolit
excret
kidney
year
inactiv
virus
use
sialidas
inhibitor
given
within
hour
increas
risk
elderli
incapacit
first
symptom
also
effect
reduc
complic
includ
infect
durat
sever
symptom
vaccin
administ
octob
novemb
anticip
increas
risk
infec
tion
januari
march
northern
hemispher
subtyp
viru
anticip
vari
consider
controversi
year
year
therefor
vaccin
strain
regard
use
overus
antibacteri
influenza
b
target
safeti
respiratori
infect
gener
agre
vaccin
establish
asthmat
howev
bacteri
infect
unlik
antibacteri
therapi
efficaci
limit
old
incapacitati
requir
use
ed
vaccin
still
develop
bacteri
infect
establish
antibacteri
therinfluenza
immun
respons
may
inadeapi
remain
valuabl
notabl
area
quat
howev
morbid
mortal
uncertainti
least
elderli
regard
contract
diseas
consider
presenc
absenc
bacteri
infect
reduc
one
studi
show
mortal
gener
may
wise
err
side
caution
reduc
hospitalis
pneumonia
use
antibacteri
degre
morbid
nasal
vaccin
effect
espemay
decis
factor
practic
antibacteri
cialli
children
furthermor
popul
spread
usual
given
us
purul
nasal
discharg
green
phlegm
use
tobacco
tonsillar
symptomat
nonspecif
exud
whether
bacteri
infect
treatment
acut
cough
establish
use
antibacteri
led
gener
physician
hesit
treat
cough
small
improv
cough
sputum
producin
acut
respiratori
condit
partli
betion
better
gener
improv
followcaus
cough
normal
last
day
probup
durat
ill
seem
abli
peak
consult
take
place
affect
anoth
extens
studi
show
believ
improv
especi
effect
improv
guidelin
deterspecif
treatment
may
also
doubt
minat
treatment
antibacteri
surround
effect
antituss
agent
publish
administ
usual
dosag
fear
bacteri
infect
definit
establish
advers
effect
especi
relev
elderli
use
antibacteri
highli
desir
especi
patient
studi
antituss
drug
elderli
recommend
american
children
nonelderli
adult
thorac
societi
cap
larg
number
reason
believ
result
gener
studi
support
view
also
appli
elderli
antibacteri
recommend
rhinosinusiobvi
specif
treatment
better
ti
bacteri
infect
upper
respiratori
aim
cure
condit
henc
allevi
symptract
frequent
bacteri
invad
tom
symptomat
treatment
may
requir
requir
appropri
antibacteri
therapi
addit
place
specif
treatment
pneumonia
h
influenza
cough
suffici
sever
cough
idiopath
main
indic
antituss
therapi
cough
prevent
sleep
inflamm
bronchodil
agocaus
cough
cough
pain
nist
shorten
durat
cough
patient
acut
laryng
chest
pain
acut
bronchibronchi
hyperrespons
wheez
ti
reason
patient
consult
effect
absenc
airflow
limit
physician
go
pharmaci
coughcold
corticosteroid
test
shorten
duraremedi
addit
reason
social
exampl
tion
cough
appar
without
effect
cough
annoy
distress
member
protuss
therapi
humidifi
air
famili
home
fellow
worker
drug
guaifenesin
wide
includ
cough
seldom
harm
unless
otc
remedi
littl
evid
prolong
excess
whoop
cough
effect
cough
young
debilit
poor
agent
use
treat
cough
nasal
gener
condit
patient
latter
appli
infect
includ
antihistamin
oral
topic
vath
elderli
patient
advers
soconstrictor
atropin
agent
corticostereffect
antituss
agent
may
caus
oid
firstgener
antihistamin
may
harm
main
advers
effect
antituss
agent
stronger
antituss
action
secondar
mental
confus
nausea
constip
espegener
drug
sinc
central
nervou
cialli
opioid
effect
especi
sed
effect
could
depress
cough
gener
undesir
elderli
respiratori
depress
agent
inhibit
nasal
patholog
also
claim
advers
effect
opioid
produc
cough
one
would
expect
also
although
seem
littl
evid
support
inhibit
cough
view
human
may
arisen
sedat
drowsi
eas
sleep
patient
ic
acut
cough
accur
relat
therapi
anim
larg
dose
opioid
need
former
conduct
close
defin
laborcaus
respiratori
depress
atori
condit
latter
notori
variabl
patient
cours
illit
believ
antituss
medic
ness
addit
grow
evid
use
cough
wet
cough
reflex
quantit
differ
health
lead
accumul
mucu
chest
compar
airway
diseas
axiom
taught
medic
student
studi
elderli
littl
evid
support
cough
airway
mucocilwhil
conveni
convent
divid
iari
transport
possibl
mucu
secret
deantituss
agent
centrallyand
peripherallypress
sleep
without
advers
effect
act
mani
drug
includ
current
use
patient
wet
cough
sleep
night
shown
act
site
least
anim
usual
advers
effect
wake
model
surpris
sinc
nerv
fibr
although
mucu
may
cough
respons
cough
stretch
airway
wall
smoker
patient
cough
includ
elderli
cough
centr
brainstem
spend
fortun
pharmaci
otc
antituscontain
mediat
pharmacolog
sive
probabl
without
pay
attent
membran
receptor
along
entir
cours
wet
dri
natur
cough
antituss
agent
abil
cross
bloodbrain
final
consider
develop
barrier
remain
unclear
studi
localfurth
regard
dosag
antituss
isat
action
antituss
drug
drug
dose
antituss
agent
either
predon
experiment
anim
applic
scribe
bought
otc
low
effechuman
question
tive
littl
better
placebo
yet
pa
name
antituss
agent
avail
tient
partner
believ
work
prescript
sold
otc
vari
greatli
base
mainli
relief
unpleas
sore
countrytocountri
follow
account
canth
enhanc
sleep
make
allow
list
avail
antituss
drug
prescrib
otc
act
either
central
centrallyact
antituss
agent
alli
chang
littl
last
decad
two
howev
last
year
central
nervou
gener
cough
take
explos
research
peripher
sensori
place
medulla
brainstem
use
central
nervou
mechan
antituss
call
cough
centr
detail
neuron
drug
profound
influenc
circuitri
complex
elucid
recentth
pharmacotherapi
cough
pharmaceut
ly
two
aspect
import
relat
industri
invest
heavili
antituss
research
cough
therapi
agent
power
cough
surpris
view
potenti
suppress
dextromethorphan
inmarket
fluenc
breath
therefor
may
act
clinic
test
antituss
respiratori
depress
effect
antituss
anim
model
patient
chronic
cough
dose
secondli
central
nervou
pathway
healthi
patient
cough
induc
tuscough
larynx
distinct
brainstem
neusigen
aerosol
qualit
applic
ronal
connect
innerv
trachethes
result
patient
acut
cough
larg
obronchi
tree
open
prospect
accept
direct
studi
would
prefer
drug
develop
specif
action
difon
might
expect
aerosolinduc
cough
mimfer
type
acut
cough
potenti
centrallyact
antituss
codein
pholcodin
among
agent
includ
antagonist
serotonin
substanc
p
popular
prescrib
otc
antituss
drug
neurokinin
opioid
receptorlik
receptor
least
uk
surpass
dextromethorglycin
glutam
involv
phan
especi
codein
potenti
receptor
cough
effect
appropriadvers
effect
includ
addict
opioid
anal
antituss
drug
studges
hydrocodon
hydromorphon
dihyi
extens
experiment
anim
drocodein
methadon
even
morphin
peripherallyact
antituss
agent
use
antituss
usual
restrict
sever
distress
termin
ill
patient
although
drug
use
central
action
opioid
antituss
drug
long
time
constitu
mani
extens
studi
experiment
anim
otc
prepar
seldom
prescrib
theat
least
four
differ
type
subtyp
opioid
oret
act
local
airway
receptor
distinguish
neuron
therefor
lack
advers
effect
centrallyact
circuitri
cough
detail
pattern
antituss
drug
action
sever
opioid
studi
nearli
form
cough
due
excitaalthough
effect
codein
tion
sensori
receptor
wall
airway
treatment
chronic
cough
suppress
inhal
irrit
inflammatori
mediat
reaerosolinduc
cough
shown
staleas
due
local
tissu
damag
within
airtist
signific
one
studi
patient
way
stimul
caus
cough
acut
cough
show
effecamong
reflex
also
lead
releas
tive
placebo
mediat
tachykinin
induc
inflammatori
chang
airway
airway
diseas
includ
infect
receptor
nonnarcot
opioid
deriv
lack
sensitis
cough
local
effect
enmani
advers
effect
opioid
hanc
extens
studi
constip
nausea
sedat
addict
howof
sensori
cough
receptor
especi
reever
may
caus
confus
effect
cent
year
unfortun
research
alagainst
chronic
acut
cough
entir
anim
model
result
aerosolinduc
cough
experiment
condibegin
influenc
antituss
treatment
tion
believ
act
nmda
receptor
human
rather
opioid
receptor
brainstem
may
explain
failur
depress
respir
local
anaesthet
includ
lidocain
ligno
cain
bupivacain
benzonat
amalthough
often
use
treat
spastic
rathbroxol
mexiletin
given
local
either
er
cough
baclofen
also
antituss
propera
aerosol
lozeng
anaesthetis
sensori
tie
respect
work
activ
receptor
airway
mucosa
may
aminobutyr
acid
receptor
brainstem
therefor
effect
acut
cough
owe
pnd
facilit
cough
effect
aerosolinor
laryng
also
reliev
pain
duce
cough
experiment
condit
exsor
given
oral
probabl
act
peperiment
anim
idiopath
ace
ripher
central
benzonat
oral
inhibitorinduc
cough
patient
although
local
anaesthet
commonli
use
especi
otc
clinic
trial
prepar
acut
bronchiti
use
aerosolis
local
anaesthet
may
riski
view
mean
result
make
statist
signific
possibl
induc
bronchoconstrict
less
like
surpris
acut
cough
variabl
patient
time
differwhil
studi
antitus
bodyweight
standard
dose
drug
sive
action
local
anaesthet
natur
inwil
caus
variat
gender
differ
duce
cough
support
effectivecough
sensit
seldom
allow
ness
similar
studi
induc
cough
healthi
par
ticip
dose
antituss
agent
includ
levodropropizin
levoclophav
shown
drug
statist
erastin
cloperastin
moguiseffect
placebo
laboratori
studi
tein
nonnarcot
nonopioid
varianc
result
would
far
smaller
metathat
act
peripher
inhibit
induc
analysi
patient
acut
cough
natur
cough
trial
cough
patient
urti
show
standard
dose
dextromeththey
effect
dextromethorphan
codeorphan
statist
effect
ine
better
placebo
placebo
even
cough
suppress
act
mainli
place
bo
effect
poor
reason
use
extens
work
experiment
anim
patient
believ
work
judg
enoridentifi
sever
differ
type
cough
sensori
mou
popular
facilit
sleep
receptor
airway
mucosa
analys
effect
small
close
membran
properti
research
placebo
lessen
likelihood
advers
led
develop
number
novel
drug
effect
includ
addict
activ
suppress
induc
cough
experiment
anim
adequ
assess
human
patient
yet
conclus
action
involv
neurokinin
opioid
nociceptin
acut
cough
caus
viral
bacteri
orphanin
vanilloid
na
channel
dopamin
pu
infect
part
respiratori
rine
pharmacolog
receptor
sensori
neutract
diagnosi
usual
base
patient
histori
rone
membran
drug
may
also
act
clinic
examin
caus
agent
may
central
nervou
system
one
number
virus
bacteria
identif
seldom
essenti
bacteri
infect
establish
antibacteri
thera
placebo
respons
antituss
drug
acut
api
may
call
especi
elderli
viral
chronic
cough
well
establish
inde
bacteri
vaccin
highli
desir
symptosom
wellconduct
studi
show
recommat
therapi
cough
may
requir
mend
dose
agent
includ
found
recent
advanc
understand
physiolmani
otc
therapi
codein
dextroogi
pharmacolog
cough
mechan
make
methorphan
statist
insignific
like
varieti
novel
antituss
drug
effect
placebo
led
avail
futur
recommend
use
treatment
encourag
although
boldi
ba
skidmor
sj
ayr
jg
acut
bronchiti
interest
directli
relev
content
manucommun
epidemiolog
agent
intervent
respir
script
med
monto
sullivan
km
acut
respiratori
ill
commun
frequenc
ill
agent
involv
epidemi
